Ticker

Analyst Price Targets — KALA

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
September 30, 2025 1:32 pmMizuho Securities$1.50$1.81TheFly Kala Bio downgraded to Neutral from Outperform at Mizuho
September 17, 2025 10:19 amH.C. Wainwright$35.00$17.47TheFly Kala Pharmaceuticals price target raised to $35 from $12 at H.C. Wainwright
August 7, 2024 6:18 amYi ChenH.C. Wainwright$7.50$3.10TheFly Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
May 17, 2024 10:34 amYi ChenH.C. Wainwright$9.00$3.25TheFly Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
April 3, 2024 6:43 amYi ChenH.C. Wainwright$10.50$4.00StreetInsider Kala Pharmaceuticals (KALA) PT Lowered to $21 at H.C. Wainwright

Latest News for KALA

Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industry TORONTO and ARLINGTON, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light” or the “Company”) and Kala Bio, Inc. (NASDAQ: KALA) (“Kala Bio”) today announced that…

GlobeNewsWire • Mar 18, 2026
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate

AI-powered autonomous research agents to be deployed in support of PEX010 clinical development strategy, leveraging Kala Bio's purpose-built agentic AI platform for the biotechnology industry Toronto, Ontario and Arlington, Massachusetts--(Newsfile Corp. - March 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Kala Bio, Inc. (NASDAQ: KALA) ("Kala Bio")…

Newsfile Corp • Mar 18, 2026
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents

Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA) Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Younet.ai, a Toronto-based AI technology company specializing in enterprise-grade private LLM solutions, today announced that the recent release of AutoResearch by AI pioneer…

Newsfile Corp • Mar 11, 2026
Stock Trend Capital Provides Younet AI Investment Update

Younet AI Partners with KALA BIO to Deploy AI Infrastructure for the Biotech Industry Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Stock Trend Capital Inc. (CSE: STCQ) (FSE: P0G) (OTC Pink: STOCF) (the "Company" or "Stock Trend") is pleased to provide shareholders with an update regarding its investment in Younet AI ("Younet"), a privately held Canadian company developing artificial-intelligence…

Newsfile Corp • Mar 9, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for KALA.

No House trades found for KALA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top